Generics - Pharmaceutical, Pricing

Filter

Current filters:

PharmaceuticalPricing

Popular Filters

1 to 25 of 92 results

Drug pricing power led by hepatitis C, diabetes and cancer

Drug pricing power led by hepatitis C, diabetes and cancer

13-06-2014

Hepatitis C, diabetes and cancer are sustaining high pricing power through innovation according to Morningstar's…

AbbVieAntibiotics and Infectious diseasesBiogen IdecCopaxoneDiabetesGenericsGilead SciencesMerck & CoOncologyPharmaceuticalPricingTecfideraTeva Pharmaceutical IndustriesUSA

Spain continues reduction of pharma spending and starts adopting value based pricing

04-02-2014

The Spanish Ministry of Health last week announced pharmaceutical spending data, which showed a new drop…

EuropeFinancialGenericsHealthcarePharmaceuticalPricingSpain

Russian government to change mechanism for setting prices for essential drugs

Russian government to change mechanism for setting prices for essential drugs

10-12-2013

The Russian government is considering changing the mechanism of setting prices for essential drugs in…

Eastern EuropeGenericsPharmaceuticalPricingRussia

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system

29-10-2013

The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…

Asia-PacificGenericsPharmaceuticalPricing

Modest growth forecast for Greek pharma market, despite unstable economy

04-10-2013

The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek…

EuropeGenericsHealthcareMarkets & MarketingPharmaceuticalPricing

Bayer in settlement over Cipro pricing

04-09-2013

A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

UNITAID helps accessing quality drugs at affordable prices

03-09-2013

At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…

Asia-PacificGenericsGlobalHealthcarePharmaceuticalPricing

Aid group urges countries not to trade away health as TPP negotiations intensify

23-08-2013

The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…

GenericsGlobalPatentsPharmaceuticalPricing

Japan's MHLW approves 367 generics, but what does this mean?

21-08-2013

Japan's Ministry of Health Labor and Welfare (MHLW) approved 367 items of generic drugs last week. Launch…

Asia-PacificDiovanGenericsNovartisPharmaceuticalPricingRegulation

Japanese government committee has kicked off reform on drug pricing system

05-08-2013

Revision of drug pricing rules in Japan gained momentum when the Council of Regulatory Reforms (CRR)…

Asia-PacificGenericsPharmaceuticalPricing

Russian government to regulate prices for essential drugs

29-07-2013

The Russian government is considering tightening its pricing policy in the domestic market for essential…

EuropeGenericsPharmaceuticalPricing

Medecins Sans Frontieres wants the Trans-Pacific Partnership to amend terms

16-07-2013

Worldwide humanitarian organization Medecins Sans Frontieres (MSF) is urging the countries participating…

Asia-PacificGenericsPatentsPharmaceuticalPricing

New study shows prices of IPHA firms' medicines in Ireland at European average

23-06-2013

The prices of Irish Pharmaceutical Healthcare Association members' medicines in Ireland are now at the…

EuropeGenericsPharmaceuticalPricing

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products

30-05-2013

UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Ireland passes legislation for reference pricing of drugs and increased generics use

29-05-2013

Irish Parliamentarians last week passed the country's Health (Pricing and Supply of Medical Goods) Bill…

EuropeGenericsLegalPharmaceuticalPricing

Russian government may change mechanism of price regulation for vital drugs

29-05-2013

Sales of essential and vital drugs in Russia rose by 16% to 37.85 billion roubles ($1.21 billion) in…

EuropeGenericsMarkets & MarketingPharmaceuticalPricing

Italy's pharma market slump set to continue, warns GlobalData

22-05-2013

The value of Italy's pharmaceutical market will continue to fall in the foreseeable future, due to government…

EuropeGenericsMarkets & MarketingPharmaceuticalPoliticsPricing

Generic medicines pricing reforms deliver significant savings to Australian government, says CSES report

22-05-2013

Australia's 2010 Pharmaceutical Benefits Scheme (PBS) reforms have delivered the government significant…

Asia-PacificFinancialGenericsHealthcarePharmaceuticalPricing

Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines

20-05-2013

India's National Pharmaceutical Pricing Authority (NPPA) last week announced plans that will bring down…

Asia-PacificGenericsPharmaceuticalPricing

Australia's 2013-14 Budget includes investment in health services and PBS

14-05-2013

The Australian government today (May 14) presented its Budget for 2013-2014, saying that it delivers…

Asia-PacificFinancialGenericsPharmaceuticalPoliticsPricing

Countries must fix critical access to medicines flaws in Trans-Pacific Trade Pact, says MSF

14-05-2013

As negotiations for the Trans-Pacific Partnership (TPP) restart in Lima, Peru, tomorrow (May 15), countries…

GenericsPatentsPharmaceuticalPoliticsPricing

Cancer treatments "unaffordable" and will drive rapid transition to generics and market decline, says GlobalData

10-05-2013

The rising prices of new cancer drugs are resulting in an increasing cost burden for patients and health…

BiotechnologyGenericsGlobalMarkets & MarketingOncologyPharmaceuticalPricing

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer

28-04-2013

The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

Portugal debt crisis strangling pharma sector growth

21-04-2013

The Portuguese pharmaceutical market has struggled in recent years, and new government policies restraining…

EuropeGenericsMarkets & MarketingPatentsPharmaceuticalPricing

1 to 25 of 92 results

Back to top